Gregory L. Weaver

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Gaithersburg, MD
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Gregory Weaver
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gregory L. Weaver

Form 4 holding Former EVP, CFO, & Director, Director

ATOSSA THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
55
Estimated value
$36
Report date
15 Nov 2023
Price
$0.6500
Ownership
Direct
Form 4 holding Former EVP, CFO, & Director, Director

ATOSSA THERAPEUTICS, INC.

Security class
Stock Option (right to buy)
Shares / value
2,600,000
Estimated value
Report date
01 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

ATAI Life Sciences N.V.

Security class
Stock Option
Shares / value
228,000
Estimated value
Report date
02 Mar 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Gregory L. Weaver

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .